Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001455875 | SCV001659642 | likely benign | Familial hypercholesterolemia | 2023-12-14 | criteria provided, single submitter | clinical testing | |
GENin |
RCV001455875 | SCV005441741 | likely benign | Familial hypercholesterolemia | 2023-09-07 | criteria provided, single submitter | clinical testing | This is a synonymous (silent) variant that is not predicted to impact splicing and occurs at a nucleotide which is not conserved. Therefore this variant has been classified as Likely Benign (BP4, BP7). |
Ambry Genetics | RCV004992290 | SCV005609347 | likely benign | Cardiovascular phenotype | 2024-12-07 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Laboratorium voor Moleculaire Diagnostiek Experimentele Vasculaire Geneeskunde, |
RCV000508937 | SCV000606099 | benign | Hypercholesterolemia, familial, 1 | no assertion criteria provided | research |